July 23, 2020

Accelerating Development of Novel and Affordable Therapies

  • Dr Chas Bountra Pro-Vice Chancellor for Innovation  Oxford University

    Dr Chas Bountra
    Pro-Vice Chancellor for Innovation Oxford University

  • Dr. Vijaya Raghavan Principal Scientific Adviser to the Government of India

    Dr. Vijaya Raghavan
    Principal Scientific Adviser to the Government of India

  • Pankaj Patel Chairman Cadilla Health Care

    Pankaj Patel
    Chairman Cadilla Health Care

  • Sharad Tyagi Managing Director  at Boehringer Ingelheim India Pvt Ltd.

    Sharad Tyagi
    Managing Director at Boehringer Ingelheim India Pvt Ltd.

To better understand the underlying challenges and the need to collaborate and build affordable treatment paradigms in a post Covid world

Context

Synergia Foundation in collaboration with the Oxford University  hosting a webinar on : Innovation  : How do we accelerate the development of more novel and affordable therapies for patients

Affordable health care is the key to a productive work force, business innovation, and the economic as well as health security of a nation  COVID-19 has firmly established the need for a  robust, collaborative and  affordable  healthcare architecture   where the role of both the government and private sector is important.

Key topics

  • The role of Brilliant leaders, innovators and entrepreneurs in providing affordable health
  • Global partnerships: academia, industry, governments, regulators, patient groups, funders
  • Open science
  • New platforms: biomarkers, AI/ machine learning

Experts

Dr Chas Bountra
Dr Chas Bountra
Pro-Vice Chancellor for Innovation Oxford University

Dr. Vijaya Raghavan
Dr. Vijaya Raghavan
Principal Scientific Adviser to the Government of India

Pankaj Patel
Pankaj Patel
Chairman Cadilla Health Care

Sharad Tyagi
Sharad Tyagi
Managing Director at Boehringer Ingelheim India Pvt Ltd.